United States · FDA National Drug Code directory
Spironolactone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65162-514_8cdb3181-3666-48aa-a197-fb3a1e082e74
- Product NDC
- 65162-514
- Form
- TABLET
- Composition / generic term
- Spironolactone
- Labeler
- Amneal Pharmaceuticals LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20100802
- Source listing expiry
- 20261231
Source-listed ingredients
- SPIRONOLACTONE — 50 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (65162-514-03) · 65162-514-03
- 60 TABLET in 1 BOTTLE (65162-514-06) · 65162-514-06
- 90 TABLET in 1 BOTTLE (65162-514-09) · 65162-514-09
- 100 TABLET in 1 BOTTLE (65162-514-10) · 65162-514-10
- 1000 TABLET in 1 BOTTLE (65162-514-11) · 65162-514-11
- 500 TABLET in 1 BOTTLE (65162-514-50) · 65162-514-50
- 100 TABLET in 1 BLISTER PACK (65162-514-60) · 65162-514-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →